Search research articles
Contact Us
Filters
Showing results (81-90 of 150) with videos related to
Page
of 15
Sort By:
Blood
|
April 1, 1978
Treatment of chronic granulocytic leukemia with melphalan
T Hauch, G Logue, J Laszlo, et al.
Molecular Pharmacology
|
November 1, 1981
Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line
M Hamrell, J Laszlo, O E Brown, et al.
Molecular Pharmacology
|
November 1, 1982
Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines
W D Sedwick, M Hamrell, O E Brown, et al.
JAMA
|
August 21, 1987
Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly
M A O'Rourke, J R Feussner, P Feigl, et al.
Archives of Internal Medicine
|
April 1, 1978
Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients
J Laszlo, R Jones, H R Silberman, et al.
Advances in Enzyme Regulation
|
January 1, 1978
Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killing
W D Sedwick, M J Fyfe, M Hamrell, et al.
The Journal of Allergy
|
March 1, 1971
Immunosuppressive therapy of asthma
T Asmundsson, K H Kilburn, J Laszlo, et al.
Cancer Treatment Reports
|
March 1, 1978
Comparison of metoprine (DDMP) and etoprine (DDEP) by measuring the inhibition of deoxyuridine incorporation into the DNA of human leukemic cells 1,2,3
J Laszlo, M J Fyfe, D Swedwick, et al.
Advances in Enzyme Regulation
|
January 1, 1984
The occurrence and consequences of deoxyuridine in DNA
R G Richards, L C Sowers, J Laszlo, et al.
Cancer Research
|
January 1, 1975
Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates
B B Baril, E F Baril, J Laszlo, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 150) with videos related to
Sort By:
Page
of 15
Blood
|
April 1, 1978
Treatment of chronic granulocytic leukemia with melphalan
T Hauch, G Logue, J Laszlo, et al.
Molecular Pharmacology
|
November 1, 1981
Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line
M Hamrell, J Laszlo, O E Brown, et al.
Molecular Pharmacology
|
November 1, 1982
Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines
W D Sedwick, M Hamrell, O E Brown, et al.
JAMA
|
August 21, 1987
Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly
M A O'Rourke, J R Feussner, P Feigl, et al.
Archives of Internal Medicine
|
April 1, 1978
Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients
J Laszlo, R Jones, H R Silberman, et al.
Advances in Enzyme Regulation
|
January 1, 1978
Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killing
W D Sedwick, M J Fyfe, M Hamrell, et al.
The Journal of Allergy
|
March 1, 1971
Immunosuppressive therapy of asthma
T Asmundsson, K H Kilburn, J Laszlo, et al.
Cancer Treatment Reports
|
March 1, 1978
Comparison of metoprine (DDMP) and etoprine (DDEP) by measuring the inhibition of deoxyuridine incorporation into the DNA of human leukemic cells 1,2,3
J Laszlo, M J Fyfe, D Swedwick, et al.
Advances in Enzyme Regulation
|
January 1, 1984
The occurrence and consequences of deoxyuridine in DNA
R G Richards, L C Sowers, J Laszlo, et al.
Cancer Research
|
January 1, 1975
Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates
B B Baril, E F Baril, J Laszlo, et al.
Page
of 15